M00.89
Polyarthritis due to other bacteria
Clinical Classification Guidelines
Medical Intelligence & Overview
Polyarthritis due to other bacteria, classified under ICD-10 code M00.89, refers to a type of joint inflammation caused by bacterial infections. This condition involves multiple joints and results from infections with various bacterial species not specifically categorized elsewhere. Recognizing this condition is crucial as it can lead to serious joint damage if not diagnosed and managed appropriately. It typically presents with joint pain, swelling, warmth, and decreased function, impactÂing individuals of diverse ages and backgrounds. This article aims to provide a clear understanding of the causes, symptoms, diagnosis, and general treatment options for this medical condition, emphasizing the importance of seeking professional healthcare for proper management.
Causes & Symptoms
Clinical Causes: Bacterial infections from various species that enter the bloodstream and localize in multiple joints. Spreading from other primary bacterial infections elsewhere in the body, such as skin or respiratory infections. Infections caused by bacteria such as Staphylococcus aureus, Streptococcus species, or gram-negative bacteria. Compromised immune system, which facilitates bacterial invasion and dissemination. Injury or trauma that allows bacteria to enter joint spaces during or after wound care.
Key Symptoms: Multiple joint pain affecting various parts of the body. Swelling and redness in affected joints. Warmth over joints due to inflammation. Reduced joint mobility or stiffness, especially in the morning. Fever and general malaise, sometimes accompanied by chills. Fatigue and feeling of overall illness. Possible signs of systemic infection depending on the severity.
Diagnostic & Treatment
Diagnosis Path: Diagnosis of polyarthritis due to bacterial sources involves a combination of medical history, physical examination, and laboratory tests. Key diagnostic procedures include: - Blood tests to identify inflammation markers such as ESR and CRP. - Blood cultures to detect bacterial presence. - Joint aspiration, or arthrocentesis, where synovial fluid is extracted for microscopic examination, Gram staining, and culture. - Imaging studies like X-rays, MRI, or ultrasound to evaluate joint integrity and exclude other causes. - Additional laboratory testing to identify specific bacteria involved, guiding targeted therapy. Early diagnosis is essential for preventing joint destruction and managing systemic infections effectively.
Treatment Protocols: Treatment strategies focus on eliminating the bacterial infection, reducing joint inflammation, and preventing long-term joint damage. Common approaches include: - Antibiotic therapy tailored to the identified bacteria, often requiring intravenous administration initially. - Supportive measures such as rest, ice application, and analgesics for pain relief. - In some cases, corticosteroids may be used to reduce inflammation. - Surgical intervention might be necessary for joint drainage or, in severe cases, joint repair. - Addressing underlying health conditions and immune status to prevent recurrences. - Follow-up care to monitor infection resolution and joint health. Therapies are usually coordinated by infectious disease specialists and rheumatologists to optimize outcomes.
Clinical Advice & FAQs
Billing Guidance
Is M00.89 a billable ICD-10 code?
Yes, M00.89 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report M00.89?
Clinical documentation must specify the nature of Polyarthritis due to other bacteria and any associated comorbidities for accurate reporting.
Cite this Clinical Reference
